Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 1,463 | 473 | 0 | 0 | 0 |
| Gross Profit | 1,463 | 473 | N/A | N/A | N/A |
| Operating Expenses | 7,709 | 7,280 | 7,622 | 7,937 | 11,459 |
| Operating Income | -6,246 | -6,807 | -7,622 | -7,937 | -11,459 |
| Other Income | -702 | 4 | -2,379 | -462 | -625 |
| Pre-tax Income | -6,948 | -6,803 | -10,001 | -8,399 | -12,084 |
| Income Tax | N/A | N/A | N/A | N/A | -999 |
| Net Income Continuous | -6,948 | -6,803 | -10,001 | -9,398 | -11,085 |
| Net Income Discontinuous | 157 | N/A | 12,898 | 1,224 | 4,161 |
| Net Income | $-6,791 | $-6,803 | $2,897 | $-8,174 | $-6,924 |
| EPS Basic Total Ops | -67,036.96 | -67,036.96 | 28,410.90 | 2,234.55 | -68,633.08 |
| EPS Basic Continuous Ops | -68,633.08 | -67,036.96 | -97,682.43 | -15,641.94 | -109,812.90 |
| EPS Basic Discontinuous Ops | 1,596.12 | N/A | 125,774.10 | 17,876.52 | 41,179.85 |
| EPS Diluted Total Ops | -67,036.96 | -67,036.96 | 28,410.90 | 2,234.55 | -68,633.08 |
| EPS Diluted Continuous Ops | -68,633.08 | -67,036.96 | -97,682.43 | -15,641.94 | -109,812.90 |
| EPS Diluted Discontinuous Ops | 1,596.12 | N/A | 125,774.10 | 17,876.52 | 41,179.85 |
| EBITDA(a) | $-5,946 | $-6,498 | $-7,167 | $-7,404 | $-10,913 |